Form D — Crosslink Therapeutics Inc.
0002067583-25-000002 · filed May 15, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $8,000,000
- Reported amount sold
- $4,250,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Crosslink Therapeutics Inc.
- CIK
- 2067583
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 349-351 NEWBURY STREET
BOSTON, Massachusetts 02115 - Phone
- 404-861-1253
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ronald D. Seidel, III · Executive OfficerBoston, Massachusetts Find on LinkedIn ↗
-
Andrew King · Executive OfficerBoston, Massachusetts Find on LinkedIn ↗
-
Lou Tartaglia · DirectorBoston, Massachusetts Find on LinkedIn ↗
-
Rodolfo Chaparro · DirectorBoston, Massachusetts Find on LinkedIn ↗
-
Cameron Gallagher · DirectorBoston, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗